Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRONTO-T2D: Ultra Rapid Lispro vs Lispro in T2D
NCT03214380Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2017
- Primary completion
- Aug 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 16
01
Overview
A Phase 3 trial of insulin lispro in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Jul 2017; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03214380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03214380.